Episode Details
Back to Episodes
What Testosterone Therapy Does to the Body (Listen if You're Thinking About Taking it)
Description
In this episode, Dr. Brandon and Dr. Morgentaler talk about the long-standing belief that testosterone therapy increases the risk of prostate cancer, a fear that has influenced medical guidelines and practice for decades.
2:23 - Charles Huggins and Prostate Cancer Theory: Dr. Morgentaler discusses Charles Huggins' Nobel-winning research that suggested testosterone could fuel prostate cancer growth.
19:56 - Impact of Low Testosterone on Quality of Life: Many men with low testosterone experience significant issues with energy, mood, and s*xual health.
29:17 - The 94-Year-Old Patient's Influence: A 94-year-old patient's decision to try testosterone therapy led Dr. Morgentaler to rethink the risks traditionally associated with treatment.
33:16 - The TRAVERSE Trial's Findings: This pivotal study demonstrated no increased prostate cancer risk among men receiving testosterone therapy compared to those who did not.
39:13 - Why Women Don't Get Prostate Cancer: Despite having analogous glandular tissue, women rarely develop prostate cancer, a topic Dr. Morgentaler examines.
Resources:
Huggins, C. (1941). Studies on prostatic cancer: The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293-297. https://doi.org/10.1158/ajc.1941.293
Morgentaler, A., Bruning, E. O., & DeWolf, W. C. (1996). Occult prostate cancer in men with low serum testosterone levels. Journal of the American Medical Association, 275(24), 1904-1906. https://doi.org/10.1001/jama.1996.03530480058034
Glaser, R., & Dimitrakakis, C. (2004). Reduced breast cancer incidence in women treated with subcutaneous testosterone implants. Maturitas, 49(4), 333-338. https://doi.org/10.1016/j.maturitas.2004.04.011
Lincoff, A. M., Harman, S. M., Mora, S., Bhatt, D. L., Carson, C., Cejka, M., ... & TRAVERSE Investigators. (2023). Cardiovascular and other long-term outcomes with testosterone use in men. New England Journal of Medicine, 388(6), 495–505. https://doi.org/10.1056/NEJMoa2215025
#ProstateCancer #TestosteroneTherapy #MedicalBeliefs
With Dr. Abraham Morgentaler and Dr. Marianne Brandon
Listen to the podcast on all of your favorite platforms:
Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB
Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7
Find us on:
Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Facebook: https://www.facebook.com/thesexdoctors
YouTube: https://www.youtube.com/@thesexdoctorspod
TikTok: https://www.tiktok.com/@thesexdoctor
LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6
LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513
X (Dr. Abraham): https://x.com/DrMorgentaler
X (Dr. Marianne): https://x.com/drbrandon